Page last updated: 2024-11-03

primaquine and Metabolic Diseases

primaquine has been researched along with Metabolic Diseases in 6 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19906 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BREWER, GJ3
TARLOV, AR3
ALVING, AS3
CARSON, PE2
NEIMANN, N1
DUCAS, J1
HIRSCHHORN, K1
KELLERMEYER, RW1
PANIZON, F1
VULLO, C1

Reviews

1 review available for primaquine and Metabolic Diseases

ArticleYear
RECENT ADVANCES IN METHODOLOGY OF HUMAN GENETICS.
    Bulletin of the New York Academy of Medicine, 1964, Volume: 40

    Topics: Antibodies; Chromosome Aberrations; Chromosome Disorders; Classification; Electrophoresis; Genetics,

1964

Other Studies

5 other studies available for primaquine and Metabolic Diseases

ArticleYear
The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis.
    JAMA, 1962, May-05, Volume: 180

    Topics: Antimalarials; Erythrocytes; Hemoglobins; Hemolysis; Humans; Metabolic Diseases; Methemoglobin; Oxid

1962
Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance.
    Archives of internal medicine, 1962, Volume: 109

    Topics: Antimalarials; Glucosephosphate Dehydrogenase Deficiency; Humans; Metabolic Diseases; Oxidoreductase

1962
[Anemia and jaundice caused by hereditary glucose-6-phosphate dehydrogenase deficit].
    Annales medicales de Nancy, 1962, Volume: 1

    Topics: Anemia; Anemia, Hemolytic; Favism; Glucosephosphate Dehydrogenase; Humans; Jaundice; Metabolic Disea

1962
Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis.
    JAMA, 1962, May-05, Volume: 180

    Topics: Antimalarials; Drug Therapy; Erythrocytes; Hemoglobins; Hemolysis; Metabolic Diseases; Oxidoreductas

1962
[Effects of the administration of fava beans and primaquine on glucose-6-phosphate dehy-drogenase-deficient erythrocytes labeled with Cr-51].
    Haematologica, 1962, Volume: 47

    Topics: Antimalarials; Erythrocytes; Glucose-6-Phosphate; Humans; Metabolic Diseases; Oxidoreductases; Prima

1962